. Author manuscript; available in PMC: 2016 May 1.

Published in final edited form as: J Subst Abuse Treat. 2014 Dec 2;52:17–23. doi: 10.1016/j.jsat.2014.11.008

Table 2.

Addiction and psychiatric medication prescription to substance dependent participants randomized to the intervention arm of the AHEAD study (N=282)

Medication	Baseline, any use in past 3 months, % (95%CI)	90 day period after 1^st CCM clinic visit, % (95%CI)

Any addiction medication (n=282)	4.6 (2.2, 7.1)	20.9 (16.3, 26.1)

Any psychiatric medication (n=282)	22.7 (17.9, 27.7)	63.8 (58.2, 69.4)

Any alcohol dependence medication, among those with alcohol dependence (n=211)	1.9 (0.1, 3.7)	17.1 (12.0, 22.1)
Naltrexone	0.0 (NA)	10.0 (5.9, 14.0)
Acamprosate	1.4 (0.0, 3.0)	7.6 (4.0, 11.1)
Disulfiram	0.5 (0.0, 1.4)	0.5 (0.0, 1.4)

Any drug dependence medication, among those with drug dependence (n=253)	4.4 (1.8, 6.9)	9.1 (5.5, 12.6)
Methadone	2.4 (0.5, 4.3)	2.8(0.7, 4.8)
Buprenorphine	0.8 (0.0, 1.9)	5.9 (3.0, 8.8)
Amantadine	0.0 (NA)	0.4 (0.0, 1.2)

CCM: Chronic care management